AI for clinical trial protocols in 2026: writing tools and digital protocols compared
Search for AI for clinical trial protocols and two different kinds of product come back mixed together. Protocol writing tools help a medical writer produce the protocol document. Digital protocol platforms take the finished protocol and turn it into the source documents, EDC build and CTMS configuration a study actually runs on. They solve different problems at different points in the study lifecycle, and a team is usually shopping for one or the other without knowing the distinction has a name.
Protocol writing tools
A protocol writing tool starts before the protocol exists. It takes a synopsis, a template library and prior protocols, and drafts the sections a medical writer would otherwise start from scratch: objectives, endpoints, eligibility criteria, the schedule of assessments. The writer edits, the sponsor reviews, and the output is a document.
Clinion eProtocol is the clearest example in this category. It generates a structured protocol draft from a study synopsis and, by the vendor's account, can produce most of a full draft for the writer to finish. General-purpose models are used the same way for individual sections, with the same caveat: a regulated document needs an accountable author, and the model is not one.
Digital protocol platforms
A digital protocol platform starts after the protocol is final. Its input is the PDF the sponsor already sent. Its output is a structured, machine-readable version of that protocol, and the operational artifacts generated from it.
Clincove's Protocol AI reads the protocol PDF and generates CDISC-aligned case report forms, visit schedules and edit checks for Clincove's own EDC. The vendor reports that about 80% of CRF content is generated accurately from the protocol, with the remaining conditional logic and sponsor-specific conventions handled by data managers.
Concordare converts the protocol PDF into the Clinical Trial Protocol Model (CTPM) with Apta, its conversion engine. The study team reviews and approves the CTPM. From it, Structura generates source documents and visit worksheets in the site's own templates, and Porta configures the EDC and CTMS the site already uses, starting with REDCap. In a June 2026 third-party assessment across 3,171 protocol data elements, Apta scored 99.62% precision and 97.47% recall. AI is used only at extraction; every document and build is generated deterministically from the approved model.
How to tell which one you need
- You have a synopsis and need a protocol document: a writing tool.
- You have a final protocol and need it built into your site's systems: a digital protocol platform.
- You are a sponsor or CRO and want every site running the protocol the same way: a digital protocol platform, because the model is the shared source of truth across sites.
- You want the AI to own the output: neither. Every product in both categories keeps a human sign-off, and regulators expect one.
Where the categories meet
The line will blur. A protocol authored as structured data does not need to be extracted from a PDF later, and CDISC's Unified Study Definitions Model points sponsors in that direction. Until protocols arrive that way, sites receive PDFs, and the digital protocol platform is the step that turns a PDF into something systems can use.
Definitions
Clinical Trial Protocol Model (CTPM). Concordare's machine-readable digital clinical trial protocol, extracted from the protocol PDF, reviewed by the study team, and used to generate source documents, EDC builds and CTMS configuration. Full definition.
Case report form (CRF). The form, paper or electronic, on which a site records each participant's protocol-required data.
Source document. The site's original record of a participant visit, from which CRF data is transcribed or against which it is verified.
Concordare publishes how the CTPM is defined and how accurately it is extracted. To see a protocol converted and the documents generated from it, request a demo.
Related posts
Company NewsConcordare Submits Public Comment to FDA on the Expedited IND Pilot Program
July 2026 · 2 min read
Company NewsConcordare Named Finalist in 2026 Fierce AI Innovation Awards
July 2026
Product UpdateAudit of Concordare's Digital Protocol AI Conversion Engine Achieves 99.6% Accuracy
July 2026 · 3 min read